DUBLIN--(BUSINESS WIRE)--The "Global Fetal And Neonatal Monitoring Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global fetal and neonatal monitoring devices market as it emerges from the COVID-19 shut down.
The global fetal and neonatal monitoring devices market is expected to grow from $7.1 billion in 2021 to $7.65 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%. The market is expected to grow to $9.74 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%.
Companies Mentioned
- GE Healthcare
- Fisher & Paykel Healthcare Limited
- Philips Healthcare
- Atom Medical Corporation
- Natus Medical Incorporated
- Analogic Corporation
- Phoenix Medical Systems (P) Ltd.
- Becton Dickinson
- Masimo Corporation
- Dragerwerk AG & Co. KGAA
- CareFusion Corporation
- Nonin Medical
- Koninklijke Philips N.V.
- Welch Allyn
- Spacelabs Healthcare
- Smiths Medical
- Getinge AB
- FUJIFILM SonoSite Inc.
- Siemens Healthcare GMBH
- Incereb ltd.
- Utah Medical Products Inc.
- OSI Systems
- Lutech Industries
- Neoventa Medical AB
- CardiacDirect
- Analogic
- International Biomedical
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Major players in the fetal and neonatal monitoring devices and equipment market are GE Healthcare, Fisher & Paykel Healthcare Limited, Philips Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Analogic Corporation, Phoenix Medical Systems (P) Ltd, Becton Dickinson, Masimo Corporation, and Dragerwerk AG & Co. KGAA
The fetal and neonatal monitoring devices and equipment market consist of sales of fetal and neonatal monitoring devices and equipment and related services. Fetal and neonatal monitoring devices and equipment are used to assess fetal heart rate and contractions of the uterus during pregnancy and childbirth. Ultrasound Dopplers and internal fetal monitors are widely-used fetal and neonatal monitors.
The main equipment of fetal and neonatal monitoring devices and equipment are fetal and neonatal. Neonatal monitoring devices and equipment are used for the monitoring of various body parameters of the newborn. The fetal and neonatal monitoring devices and equipment are portable or non-portable. Fetal care equipment types are ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Neonatal care equipment types are infant warmers, incubators, convertible warmers and incubators, phototherapy equipment, respiratory devices, neonatal monitoring devices, and diagnostic imaging devices. The various end-users are hospitals, diagnostic centers, pediatric clinics, and ambulatory surgical centers.
Asia Pacific was the largest region in the fetal and neonatal monitoring devices and equipment market in 2021. North America was the second-largest region in the fetal and neonatal monitoring devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The increasing prevalence of preterm births and the low body weight of infants act as a factor driving the fetal and neonatal monitoring devices market growth. Preterm birth refers to the premature birth of a child before 37 weeks gestation period, which leads to poor health and growth, mental retardation, visual and hearing impairments, cerebral palsy, and others.
The fetal and neonatal monitoring device market is restricted by stringent regulatory policies governing this market. The fetal and neonatal device manufacturers need to pass through several tests and requirements laid down by different regulatory bodies. Regulations like FDA's Center for Devices and Radiological Health (CDRH), NMPA regulations, EU directives lay down some stringent regulations for this equipment.
The changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes lead to increased healthcare costs. For instance, according to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR.
The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). Furthermore, the FDA is requesting more clinical data to support claims resulting in increased processing times of 510(k)s by over 55% over the last decade, thus delaying the operating cycle of manufacturers in this market.
Fetal and neonatal monitoring device manufacturers are increasingly innovating and integrating technologies such as wireless technology with patient monitoring devices to efficiently diagnose and monitor fetuses and newborns. Wireless sensor technology such as biosensor monitoring devices, wireless fetal heart rate monitoring devices is multi-sensor systems implanted or embedded into the skin, consisting of a sensor that transmits data for real-time monitoring of a patient's medical condition.
The countries covered in the fetal and neonatal monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.
For more information about this report visit https://www.researchandmarkets.com/r/jhjs95
